Qiagen NV Share Price Today: Live Updates & Key Insights

Qiagen NV share price today is $39.93, up -1.77%. The stock opened at $40.33 against the previous close of $40.65, with an intraday high of $40.42 and low of $39.8.

Qiagen NV Share Price Chart

Qiagen NV

us-stock
To Invest in {{usstockname}}
us-stock

Qiagen NV Share Price Performance

$39.93 -0.0177(-1.77%) QGEN at 23 Mar 2026 02:55 PM Diagnostics & Research
Lowest Today 39.8
Highest Today 40.42
Today’s Open 40.33
Prev. Close 40.65
52 Week High 57.82
52 Week Low 36.00
Day’s Range: Low 39.8 High 40.42
52-Week Range: Low 36.00 High 57.82
1 day return -
1 Week return -2.39
1 month return -15.9
3 month return -13.27
6 month return -12.65
1 year return +0.27
3 year return -13.13
5 year return -20.37
10 year return -

Qiagen NV Institutional Holdings

Massachusetts Financial Services Company 11.16

Wellington Management Company LLP 6.52

Vanguard Group Inc 4.40

T. Rowe Price Associates, Inc. 3.47

Deutsche Bank AG 3.32

BlackRock Inc 2.45

MFS International Equity 2.34

MFS International Equity R6 2.34

Vanguard Health Care Inv 2.13

MFS International Growth A 2.08

Morgan Stanley - Brokerage Accounts 2.02

Amundi 1.95

Earnest Partners LLC 1.93

T. Rowe Price International Gr Eq Tr-D 1.86

Boston Partners Global Investors, Inc 1.83

NORGES BANK 1.68

T. Rowe Price International Growth Eq 1.57

Bank of America Corp 1.51

Allspring Global Investments Holdings, LLC 1.46

Vanguard Total Intl Stock Index Inv 1.44

T. Rowe Price International Stock 1.44

MFS International Research Equity 1.36

MFS Research International I 1.36

JHancock Disciplined Value Mid Cap I 1.33

Fivespan Partners, LP 1.31

Capital Research & Mgmt Co - Division 3 1.19

Folksam LO Världen 1.19

Allspring Mid Value SMA 1.17

Allspring Special US Mid Cap Value Eq 1.17

State Street Corp 1.00

Allspring Special Mid Cap Value Inst 0.96

Vanguard Developed Markets Index Admiral 0.94

SEI Investments Co 0.88

DWS ESG Investa LD 0.86

MFS International Equity CIT -Cl4 0.82

Universal- Beteiligungs- und Servicegesellschaft mbH 0.82

The Goldman Sachs Group Inc 0.71

Allianz Asset Management AG 0.71

Qiagen NV Market Status

Strong Buy: 6

Buy: 3

Hold: 7

Sell: 0

Strong Sell: 0

Qiagen NV Fundamentals

Market Cap 8228.57 M

PB Ratio 2.1779

PE Ratio 19.5735

Enterprise Value 8781.05 M

Total Assets 6295.96 M

Volume 2137145

Qiagen NV Company Financials

Annual Revenue FY25:2089998999 2090.0M, FY23:1954133000 1954.1M, FY22:2141518000 2141.5M, FY21:2251657000 2251.7M, FY20:1870346000 1870.3M

Annual Profit FY25:1291495000 1291.5M, FY23:1235112000 1235.1M, FY22:1384563000 1384.6M, FY21:1450820000 1450.8M, FY20:1227810000 1227.8M

Annual Net worth FY25:424880000 424.9M, FY23:332483000 332.5M, FY22:423211000 423.2M, FY21:512599000 512.6M, FY20:73640000 73.6M

Quarterly Revenue Q4/2025:540420000 540.4M, Q3/2025:532583000 532.6M, Q2/2025:533540000 533.5M, Q1/2025:483456000 483.5M, Q3/2024:501869000 501.9M

Quarterly Profit Q4/2025:317269000 317.3M, Q3/2025:331259000 331.3M, Q2/2025:334286000 334.3M, Q1/2025:308681000 308.7M, Q3/2024:308307000 308.3M

Quarterly Net worth Q4/2025:107829000 107.8M, Q3/2025:130043000 130.0M, Q2/2025:96250000 96.3M, Q1/2025:90758000 90.8M, Q3/2024:98056000 98.1M

About Qiagen NV & investment objective

Company Information Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services. The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Organisation Diagnostics & Research

Employees 5700

Industry Diagnostics & Research

CEO Mr. Thierry Bernard

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Qiagen NV FAQs

What is the share price of Qiagen NV today?

The current share price of Qiagen NV is $39.93.

Can I buy Qiagen NV shares in India?

Yes, Indian investors can buy Qiagen NV shares by opening an international trading and demat account with Motilal Oswal.

How to buy Qiagen NV shares in India?

You can easily invest in Qiagen NV shares from India by:

Can I buy fractional shares of Qiagen NV?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Qiagen NV?

Qiagen NV has a market cap of $8228.57 M.

In which sector does Qiagen NV belong?

Qiagen NV operates in the Diagnostics & Research sector.

What documents are required to invest in Qiagen NV stocks?

To invest, you typically need:

What is the PE and PB ratio of Qiagen NV?

The PE ratio of Qiagen NV is 19.57 and the PB ratio is 2.18.